Identification of Eplet Mismatches Associated with De Novo Donor Specific HLA Antibody in a Pediatric Kidney Transplant Cohort

被引：0
|
作者：
Charnaya, O. [1 ]
Jones, J. [1 ]
Chiang, P. [1 ]
Philogene, M. C. [1 ]
Garonzik-Wang, J. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B-55
引用
收藏
页码：1017 / 1017
页数：1
相关论文
共 50 条
  • [21] Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?
    Wen, Jiqiu
    Basu, Arpita
    Bentall, Andrew
    Henderson, Nicole
    Dukek, Brian
    Gandhi, Manish
    Schinstock, Carrie
    HUMAN IMMUNOLOGY, 2021, 82 (04) : 240 - 246
  • [22] Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant
    Wiebe, C.
    Gibson, I. W.
    Blydt-Hansen, T. D.
    Karpinski, M.
    Ho, J.
    Storsley, L. J.
    Goldberg, A.
    Birk, P. E.
    Rush, D. N.
    Nickerson, P. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) : 1157 - 1167
  • [23] HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients
    Zhang, Xiaohai
    Kransdorf, Evan
    Levine, Ryan
    Patel, Jignesh K.
    Kobashigawa, Jon A.
    HUMAN IMMUNOLOGY, 2020, 81 (07) : 330 - 336
  • [24] Correlation of Kidney Transplant Human Leukocyte Antigen Eplet Mismatching to De Novo Donor Specific Antibody Production and Post-Transplant Outcomes.
    Samudralwar, R.
    Szempruch, K.
    Reuter, C.
    Franz, B.
    Lee, R.
    Weimer, E.
    Detwiler, R.
    Kozlowski, T.
    Schmitz, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 768 - 768
  • [25] Risk HLA-DQ Heterodimer Mismatch Is Associated with De Novo Donor-Specific Antibodies in Pediatric Kidney Transplant Recipients
    Sigurjonsdottir, Vaka
    Piburn, Kim H.
    Wang, Lin
    Turudic, Daniel
    Grimm, Paul C.
    Tambur, Anat R.
    Zhang, Bing M.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [26] Incidence and risk factors for de novo donor-specific antibody development post pediatric kidney transplant: Retrospective analysis of longitudinal cohort
    Alshami, Alanoud A.
    Azzam, Ahmed A.
    Al Attas, Rabab A.
    Hamed, Ammar
    Kasem, Mohammed F.
    Almaghrabi, Mohammed A.
    Hassan, Abdulaziz K.
    Khalifa, Fatimah H.
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [27] HLA-DR/DQ eplet mismatch predicts risk of de novo donor-specific fi c antibody development in a multi-ethnic Southeast Asian cohort of kidney transplant recipients
    Wong, E.
    Vathsala, A.
    Sran, H.
    D'Costa, M.
    Chang, Z.
    Wiebe, C.
    HUMAN IMMUNOLOGY, 2024, 85
  • [28] The Presence of De Novo Donor Specific Anti-HLA Antibody Is Associated with Medication Nonadherence and Allograft Loss in Pediatric Renal Transplant Recipients
    Tzeng, J.
    Ettenger, R. B.
    Reed, E. F.
    Gjertson, D.
    Narayan, S.
    Puliyanda, D.
    Tsai, E. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 312 - 313
  • [29] IMPACT OF DE NOVO DONOR SPECIFIC ANTIBODY ACCORDING TO THE TRANSPLANT TYPE IN KIDNEY TRANSPLANTATION
    Park, Woo Yeong
    Kim, Yaerim
    Paek, Jin Hyuk
    Jin, Kyubok
    Roh, Young-Nam
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2021, 34 : 290 - 291
  • [30] Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients
    Sonia Solomon
    Adriana Colovai
    Marcela Del Rio
    Nicole Hayde
    Pediatric Nephrology, 2020, 35 : 261 - 270
12345